Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline

    Sheyu, Li; Per, Vandvik; Lyubov, Lytvyn; Guyatt, Gordon; Palmer, Suetonia.
    BMJ (Online); 373 (), 2021
    Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...
    Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico, Receptor del Péptido 1 Similar al Glucagón/uso terapéutico, Diabetes Mellitus Tipo 2/tratamiento farmacológico, Control Glucémico/normas, Glucemia/efectos de los fármacos
    Texto completo

    Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

    Peters, AL; Ahmann, AJ; Battelino, T; Evert, A; Hirsch, IB; Murad, MH; Winter, WE; Wolpert, H.
    J. clin. endocrinol. metab; 101 (11), 2016
    "OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
    Glucemia, Terapia Combinada, Diabetes Mellitus Tipo 1, Diabetes Mellitus Tipo 2, Dieta para Diabéticos, Monitoreo de Drogas, Endocrinología, Hiperglucemia, Hipoglucemia, Insulina/uso terapéutico, Sistemas de Infusión de Insulina, Monitoreo Ambulatorio, Educación del Paciente como Asunto, Medicina de Precisión, Diabetes Mellitus Tipo 1/tratamiento farmacológico, Diabetes Mellitus Tipo 2/tratamiento farmacológico, Diabetes Mellitus Tipo 1/terapia, Diabetes Mellitus Tipo 2/terapia, Hipoglucemiantes/uso terapéutico, Hipoglucemiantes/efectos adversos, Insulina/efectos adversos
    Texto completo